June 2023 - Wellthy Therapeutics

Monthly Archives: June 2023

Wellthy Therapeutics adds Beyond Next Ventures as an investor; Expands into Japan

Wellthy Therapeutics Product Suite

Wellthy Therapeutics has secured additional financing, led by Beyond Next Ventures. This paves the way for Wellthy Therapeutics to expand its platform into the Japanese market, enabling enterprise customers to deploy world class digital health solutions to support their patients globally.

Enhancing Well-being and Symptom Management in Hemophilia: A Digital Behavioral Therapy Approach

This paper provides an in-depth analysis of Hemophilia, a rare genetic bleeding disorder that impedes the blood’s ability to clot, leading to spontaneous or post-injury bleeding. This condition manifests in physical challenges such as joint pain, swelling, stiffness, and potential neurological complications. The psychological ramifications of these physical symptoms often result in elevated levels of stress, anxiety, and depression.